TY - JOUR
T1 - Eosinophilic esophagitis
T2 - When to suspect and why to treat with proton pump inhibitors
AU - Souza, Rhonda F.
N1 - Funding Information:
Rhonda F. Souza, M.D. has served as a consultant and receives research support from Ironwood Pharmaceuticals. This work was supported by the National Institutes of Health (R01 DK103598, National Institutes of HealthR01 DK063621, National Institutes of HealthR21 DK111369 to R.F.S.).
Funding Information:
Acknowledgment: Rhonda F. Souza, M.D. has served as a consultant and receives research support from Ironwood Pharmaceuticals. This work was supported by the National Institutes of Health (R01 DK103598, R01 DK063621, R21 DK111369 to R.F.S.)
Publisher Copyright:
© 2019, Shugar Publishing Inc. All rights reserved.
PY - 2019/1
Y1 - 2019/1
N2 - Eosinophilic esophagitis (EoE) is a chronic, immune-mediated disease driven by food allergens that manifests with symptoms of esophageal dysfunction and eosinophil-predominate esophageal inflammation. Since the early 1990s, the frequency of EoE has exploded for unclear reasons. Treatment of EoE with diet therapy or topical steroids, which are potent anti-inflammatory agents, makes sense for management of an allergic condition triggered by food antigens. Recent consensus guidelines now include proton pump inhibitor therapy as an alternative first-line treatment. This review will provide an overview of when to suspect and how to diagnosis EoE, concepts surrounding pathogenesis and increasing incidence of this newly recognized esophageal condition, and a discussion on why proton pump inhibitors are now being used as a first-line treatment strategy.
AB - Eosinophilic esophagitis (EoE) is a chronic, immune-mediated disease driven by food allergens that manifests with symptoms of esophageal dysfunction and eosinophil-predominate esophageal inflammation. Since the early 1990s, the frequency of EoE has exploded for unclear reasons. Treatment of EoE with diet therapy or topical steroids, which are potent anti-inflammatory agents, makes sense for management of an allergic condition triggered by food antigens. Recent consensus guidelines now include proton pump inhibitor therapy as an alternative first-line treatment. This review will provide an overview of when to suspect and how to diagnosis EoE, concepts surrounding pathogenesis and increasing incidence of this newly recognized esophageal condition, and a discussion on why proton pump inhibitors are now being used as a first-line treatment strategy.
UR - http://www.scopus.com/inward/record.url?scp=85073360847&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85073360847&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:85073360847
SN - 0277-4208
VL - 43
SP - 21
EP - 28
JO - Practical Gastroenterology
JF - Practical Gastroenterology
IS - 1
ER -